Not to mention the broker underwriting the options, seems most were happy to exercise options, looks like buy side building, could be interesting.....
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025